Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Food Chem Toxicol ; 38(10): 925-38, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11039326

RESUMEN

The potential of the antibiotics chloramphenicol succinate (CAPS) and thiamphenicol (TAP) to induce aplastic anaemia in the female BALB/c mouse was investigated. CAPS was administered at 2000 mg/kg, and TAP at 850 mg/kg, daily by gavage, for 17 days. At 1, 13, 22, 41, 98 and 179 days after the final dose of each antibiotic, mice (n = 4 or 5) were sampled for haematological examination and haematopoietic stem cell assays. Both CAPS and TAP induced significant reductions in red blood cell count, haematocrit and haemoglobin values at day 1 post dosing; counts of colony-forming units-erythroid and colony-forming units-granulocyte-macrophage, were similarly significantly decreased at this time. All these reduced parameters returned towards normal at days 13 and 22. At days 41, 98 and 179, results for all haematological values and stem cell assays in both CAPS- and TAP-treated mice compared with the controls; there was no evidence of a reduction in peripheral blood values or bone marrow parameters at the later sampling points, as would be expected in a developing or overt bone marrow aplasia. We therefore consider that the administration of CAPS and TAP, which have been associated with the development of aplastic anaemia in man, induce a reversible anaemia, but not a chronic bone marrow aplasia, when given at haemotoxic dose levels for 17 days in the BALB/c mouse.


Asunto(s)
Anemia Aplásica/inducido químicamente , Cloranfenicol/toxicidad , Inhibidores de la Síntesis de la Proteína/toxicidad , Tianfenicol/toxicidad , Anemia Aplásica/sangre , Animales , Células de la Médula Ósea/efectos de los fármacos , Células Madre Hematopoyéticas/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Células Progenitoras Mieloides/efectos de los fármacos , Factores de Tiempo
3.
Hum Exp Toxicol ; 18(9): 566-76, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10523871

RESUMEN

1. Chloramphenicol has been widely used in the treatment of serious infections including typhoid fever and meningitis. However, the drug is haemotoxic in man inducing firstly, a reversible, dose-dependent anaemia which develops during treatment, secondly, an often fatal aplastic anaemia with pancytopenia and acellular marrow, and thirdly, leukaemia. 2. We investigated the haemotoxicity of chloramphenicol succinate (CAPS) in female CD-1 mice in repeat dose studies, to compare the response with the reversible anaemia reported in man. Studies in male Wistar Hanover rats were also carried out. 3. CAPS was gavaged daily to mice at dose levels from 800 - 2000 mg/kg for seven days. Values were significantly reduced for reticulocytes at 1700 and 2000 mg/kg, and for erythrocytes (RBC), haematocrit (HCT), and haemoglobin (Hb) at 2000 mg/kg. Platelet and white blood cell (WBC) counts were unaffected. 4. Mice were dosed with CAPS at 1400 mg/kg for 10 days and sampled at 1, 4 and 15 days after the last dose. At day 1 post dosing, RBC, HCT and Hb values were significantly reduced, but returned to normal (or above normal) by day 4 or 15. 5. CAPS from 2000 - 4000 mg/kg was gavaged to rats daily for 19 days. Hb values were significantly lower at 3600 and 4000 mg/kg; reticulocytes were not reduced. WBC and platelet counts, in general, were unaffected. 6. Levels of apoptosis in marrow mononuclear cells were increased in CAPS-treated mice, but not in CAPS-treated rats. Serum biochemistry parameters, in general, showed few changes of toxicological significance. 7. We conclude that the administration of CAPS to CD-1 mice induced haematological changes showing close parallels with the chloramphenicol-induced reversible anaemia seen in man.


Asunto(s)
Anemia Aplásica/inducido químicamente , Cloranfenicol/análogos & derivados , Células Madre Hematopoyéticas/efectos de los fármacos , Anemia Aplásica/patología , Animales , Apoptosis/efectos de los fármacos , Recuento de Células Sanguíneas/efectos de los fármacos , Médula Ósea/efectos de los fármacos , Médula Ósea/patología , Cloranfenicol/administración & dosificación , Cloranfenicol/toxicidad , Pruebas de Química Clínica , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Pruebas Hematológicas , Células Madre Hematopoyéticas/patología , Etiquetado Corte-Fin in Situ , Masculino , Ratones , Ratones Endogámicos BALB C , Ratas , Ratas Wistar , Especificidad de la Especie
4.
Jikken Dobutsu ; 43(4): 499-502, 1994 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7805793

RESUMEN

Anti-human CD4 monoclonal antibodies have been successfully used to label T-lymphocytes in Cynomolgus monkeys by two different methods. A magnetisable bead separation was used prior to immunogold labelling of lymphocytes in one of the methods. In addition, an assay for soluble CD4 has been applied to the sera of these monkeys.


Asunto(s)
Antígenos CD4/sangre , Linfocitos T CD4-Positivos/inmunología , Macaca fascicularis/inmunología , Animales , Ensayo de Inmunoadsorción Enzimática , Femenino , Inmunohistoquímica , Masculino , Solubilidad
5.
J Comp Pathol ; 111(1): 107-11, 1994 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7962723

RESUMEN

Absolute and percentage reticulocyte counts for sequestrated blood samples from healthy Wistar rats (n = 132) and beagles (n = 64) were made by thiazole orange and flow cytometry. The flow cytometric method showed good agreement with a manual counting method for both species, and the precision data for both of these counting methods were similar.


Asunto(s)
Perros/sangre , Citometría de Flujo/veterinaria , Recuento de Reticulocitos/veterinaria , Animales , Ratas , Ratas Wistar/sangre , Recuento de Reticulocitos/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA